{"body":"<div class=\"new_recommend \">&#13;\n<h5>Recommendation (2020)<\/h5>&#13;\n&#13;\n<p><strong>ART should be initiated as soon as possible among people with disseminated histoplasmosis for whom central nervous system involvement is not suspected or proven<\/strong> <em>(conditional recommendation, very-low-certainty evidence).<\/em><\/p>&#13;\n&#13;\n<div class=\"footer\"><em>Source: Guidelines for diagnosing and managing disseminated histoplasmosis among people living with HIV (53).<\/em><\/div>&#13;\n<\/div>&#13;\n&#13;\n<h5>Background and rationale<\/h5>&#13;\n&#13;\n<h5>Systematic review<\/h5>&#13;\n&#13;\n<p>The systematic review sought to compare the outcomes of early versus delayed initiation of ART among people with histoplasmosis. One randomized clinical trial with 282 participants met the inclusion criteria <em>(74).<\/em> Based on limited evidence, the efficacy and safety outcomes of early versus late initiation of ART are unknown <em>(75).<\/em><\/p>&#13;\n&#13;\n<h5>Recommendation<\/h5>&#13;\n&#13;\n<p>ART should not be delayed for people diagnosed with disseminated histoplasmosis who are receiving antifungal therapy. The recommendation is conditional, with very-low-certainty evidence. The recommendation is based the low incidence of immune reconstitution inflammatory syndrome among people living with HIV receiving ART who have histoplasmosis <em>(76).<\/em><\/p>&#13;\n&#13;\n<p>This recommendation regarding the timing of ART only applies to people without central nervous system involvement, to avoid immune reconstitution syndrome in the central nervous system. Chapter 5 provides details on diagnosis, prevention and management of histoplasmosis.<\/p>&#13;\n","title":"4.5.4 Timing of ART for people living with HIV and histoplasmosis","nid":523,"vid":2247,"created":1631628876,"changed":1631723364,"field_content_type":{"tid":1,"name":"Content","class":"content"}}